Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)
China · Delayed Price · Currency is CNY 4.260
-0.100 (-2.29%)
May 21, 2026, 3:00 PM CST
SHA:603669 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -171.66 | -193.24 | -130.76 | -151.5 | -195.86 | 65.9 |
Depreciation & Amortization | 32.93 | 32.93 | 31.19 | 46.31 | 45.32 | 43.1 |
Other Amortization | 3.51 | 3.51 | 8.63 | 3.7 | 4.63 | 5.61 |
Loss (Gain) From Sale of Assets | -3.53 | -3.53 | -0.08 | -0.08 | -0.45 | 0.01 |
Asset Writedown & Restructuring Costs | 42.84 | 42.84 | 32.39 | 8.39 | 9.01 | 1.76 |
Loss (Gain) From Sale of Investments | 2.41 | 2.41 | 14.59 | 14.53 | 8.12 | -16.86 |
Provision & Write-off of Bad Debts | - | - | 18.77 | 10.05 | 6.94 | 0.27 |
Other Operating Activities | -16.96 | 20.28 | -4.93 | 3.71 | 5.69 | 17.81 |
Change in Accounts Receivable | 6.32 | 6.32 | -201.43 | 4.81 | 46.64 | 42.65 |
Change in Inventory | -59.64 | -59.64 | 26.26 | -17.34 | 1.55 | 15.83 |
Change in Accounts Payable | -26.01 | -26.01 | 92.93 | 39.85 | -4.71 | -45.06 |
Change in Other Net Operating Assets | 41.74 | 41.74 | - | - | - | - |
Operating Cash Flow | -148.53 | -132.87 | -110.89 | -37.87 | -66.36 | 128.5 |
Operating Cash Flow Growth | - | - | - | - | - | 1.33% |
Capital Expenditures | -4.06 | -2.68 | -8.85 | -23.13 | -42.84 | -54.82 |
Sale of Property, Plant & Equipment | 6.96 | 7.01 | 2.07 | 0.18 | 2.62 | 0.01 |
Investment in Securities | 9.7 | 9.7 | 359.47 | -44.56 | 159.33 | -396.76 |
Other Investing Activities | 1.1 | 18.44 | 13.1 | 15.61 | 12.43 | 18.72 |
Investing Cash Flow | 13.69 | 32.46 | 365.79 | -51.9 | 131.54 | -432.85 |
Short-Term Debt Issued | - | - | - | - | 205.11 | 480 |
Long-Term Debt Issued | - | 15 | - | 117.35 | - | 6.7 |
Total Debt Issued | 35 | 15 | - | 117.35 | 205.11 | 486.7 |
Short-Term Debt Repaid | - | - | - | - | -545 | -599.57 |
Long-Term Debt Repaid | - | - | -324.73 | -208.44 | -2.29 | -4.28 |
Total Debt Repaid | - | - | -324.73 | -208.44 | -547.29 | -603.85 |
Net Debt Issued (Repaid) | 35 | 15 | -324.73 | -91.09 | -342.18 | -117.14 |
Repurchase of Common Stock | - | - | -1.65 | -52.11 | -56.26 | - |
Common Dividends Paid | -6.72 | -6.59 | -5.73 | -8.08 | -80.13 | -159.21 |
Other Financing Activities | -4.07 | -2.07 | 10.04 | -7.71 | 5.23 | -2.54 |
Financing Cash Flow | 24.2 | 6.34 | -322.08 | -158.99 | -473.35 | -278.89 |
Net Cash Flow | -110.63 | -94.06 | -67.18 | -248.76 | -408.16 | -583.24 |
Free Cash Flow | -152.59 | -135.55 | -119.74 | -61.01 | -109.2 | 73.69 |
Free Cash Flow Growth | - | - | - | - | - | 13.60% |
Free Cash Flow Margin | -42.52% | -42.03% | -31.53% | -30.99% | -37.75% | 9.95% |
Free Cash Flow Per Share | -0.21 | -0.19 | -0.17 | -0.09 | -0.15 | 0.10 |
Cash Income Tax Paid | 11.73 | 15.24 | 7.92 | 13.43 | 21.39 | 82.51 |
Levered Free Cash Flow | -128.14 | -107.88 | -113.77 | -35.79 | -56 | -163.69 |
Unlevered Free Cash Flow | -128.14 | -107.88 | -96.66 | -33.48 | -52.35 | -154 |
Change in Working Capital | -38.05 | -38.05 | -80.68 | 27.01 | 50.25 | 10.9 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.